EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis

Hong Li, Zhanqi Li, Qianke Deng, Sumeng Wang, Tingting Peng, Junyi Zhang, Shanshan Cai, Wenju Pan, Xiaoxuan Ye

International Journal of Clinical Practice · 2026-01 · 2026 (1)

DOI: 10.1155/ijcp/3375907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 08.07.2026. Verfasst von Hong Li und 8 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcoidosis is a complex granulomatous disease with a substantial heritable component, yet its genetic basis beyond the HLA region remains largely unexplored, limiting progress toward precision therapeutics.

Methods

We performed a comprehensive multiomics analysis by leveraging genome‐wide association study (GWAS) data from the FinnGen consortium (5411 cases; 492,311 controls) and expression quantitative trait loci (eQTL) data from the GTEx v8 project across 49 tissues. Cross‐tissue transcriptome‐wide association studies (TWASs) were conducted using two complementary approaches, UTMOST and sCCA‐ACAT, followed by Bayesian colocalization and Mendelian randomization (MR) to support causal prioritization. Genetically informed spatial mapping (gsMap) was applied to spatial transcriptomics (ST) data from patient muscular sarcoidosis tissue to delineate the cellular specificity of identified genetic associations.

Results

Cross‐tissue TWAS analyses consistently identified three novel, non‐MHC susceptibility genes: RFTN2 , FAM117B , and RNF215 . Bayesian colocalization confirmed shared causal variants, and MR demonstrated that genetically predicted higher expression of RFTN2 and FAM117B was causally associated with a decreased risk of sarcoidosis, while elevated RNF215 expression was associated with an increased risk. ST mapping further localized these genetic signals to granuloma‐associated macrophage populations within patient muscular sarcoidosis tissue.

Conclusion

This study expands the genetic landscape of sarcoidosis beyond the classical HLA locus, uncovering novel susceptibility genes involved in membrane raft organization and ubiquitin‐mediated proteolysis. RFTN2 , FAM117B , and RNF215 emerge as promising candidate targets for future functional studies and therapeutic development in sarcoidosis.

Zitieren

APA

Li, H., Li, Z., Deng, Q., Wang, S., Peng, T., Zhang, J., Cai, S., Pan, W., & Ye, X. (2026). Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/3375907

Vancouver

Li H, Li Z, Deng Q, Wang S, Peng T, Zhang J, et al. Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/3375907

BibTeX
@article{Li2026,
  author = {Li, Hong and Li, Zhanqi and Deng, Qianke and Wang, Sumeng and Peng, Tingting and Zhang, Junyi and Cai, Shanshan and Pan, Wenju and Ye, Xiaoxuan},
  title = {Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis},
  journal = {International Journal of Clinical Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijcp/3375907}
}
Kostenlos starten →